Home › NDC Lookup › RxCUI directory › RxCUI 242461

Cilostazol 100 MG Oral Tablet — RxCUI 242461

RxNorm drug concept · Semantic clinical drug
RxCUI 242461 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 19 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI242461
Official nameCilostazol 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped19
Reported Medicaid activity (SDUD)94,949 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cilostazol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cilostazol helps with a condition called intermittent claudication — that's the cramping or aching you feel in your legs when you walk, caused by arteries that are too narrow to de...
  • What exactly does cilostazol do, and why did my doctor prescribe it for leg pain?
  • Yes, timing around meals really does matter with this one. Take your tablet at least 30 minutes before eating, or wait 2 hours after a meal. A high-fat meal can push up to 90% more...
  • How do I take it, and does it matter whether I eat first?
📖 Read our full Cilostazol guide →

🕸️ Concept Web — How Cilostazol 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cilostazol 100 MG Oral Tablet RxCUI 242461

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cilostazol 21107
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cilostazol Oral Tablet 371508
    • Cilostazol Oral Product 1163137
    • Cilostazol Pill 1163138
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cilostazol 100 MG 315675

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cilostazol 100 MG SCDC · 315675
  • Cilostazol Oral Tablet SCDF · 371508
  • Cilostazol Oral Product SCDG · 1163137
  • Cilostazol Pill SCDG · 1163138

📦 FDA Products & Package NDCs

14 products · 19 package NDCs
19 package NDCs map to RxCUI 242461 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-2064-06 60 TABLET in 1 BOTTLE (0093-2064-06) Cilostazol Teva Pharmaceuticals USA, Inc. 2012-10-24
00093-2064-50 5000 TABLET in 1 BOTTLE (0093-2064-50) Cilostazol Teva Pharmaceuticals USA, Inc. 2012-10-24
00093-2065-06 60 TABLET in 1 BOTTLE (0093-2065-06) Cilostazol Teva Pharmaceuticals USA, Inc. 2012-04-24
42291-0453-60 60 TABLET in 1 BOTTLE (42291-453-60) cilostazol AvKARE 2022-04-12
50268-0176-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-176-15) / 1 TABL... cilostazol AvPAK 2016-10-18
50268-0177-15 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-177-15) / 1 TABL... cilostazol AvPAK 2016-10-18
60505-2521-01 60 TABLET in 1 BOTTLE (60505-2521-1) cilostazol Apotex Corp. 2011-10-18
60505-2521-03 30 TABLET in 1 BOTTLE (60505-2521-3) cilostazol Apotex Corp. 2011-10-18
60505-2521-08 1000 TABLET in 1 BOTTLE (60505-2521-8) cilostazol Apotex Corp. 2011-10-18
60505-2522-01 60 TABLET in 1 BOTTLE (60505-2522-1) cilostazol Apotex Corp. 2011-10-18
60505-2522-03 30 TABLET in 1 BOTTLE (60505-2522-3) cilostazol Apotex Corp. 2011-10-18
60505-2522-08 1000 TABLET in 1 BOTTLE (60505-2522-8) cilostazol Apotex Corp. 2011-10-18
62135-0983-60 60 TABLET in 1 BOTTLE (62135-983-60) Cilostazol Chartwell RX, LLC 2025-08-27
62135-0986-60 60 TABLET in 1 BOTTLE (62135-986-60) Cilostazol Chartwell RX, LLC 2025-08-27
63629-8795-01 60 TABLET in 1 BOTTLE (63629-8795-1) Cilostazol Bryant Ranch Prepack 2012-10-24
70436-0156-06 60 TABLET in 1 BOTTLE (70436-156-06) Cilostazol Slate Run Pharmaceuticals, LLC 2021-04-16
70436-0157-06 60 TABLET in 1 BOTTLE (70436-157-06) Cilostazol Slate Run Pharmaceuticals, LLC 2021-04-16
71610-0813-26 1200 TABLET in 1 BOTTLE (71610-813-26) cilostazol Aphena Pharma Solutions - Tennessee, LLC 2024-04-03
71610-0822-26 1200 TABLET in 1 BOTTLE (71610-822-26) cilostazol Aphena Pharma Solutions - Tennessee, LLC 2024-04-12
Observed labelers: Apotex Corp. (6) · Teva Pharmaceuticals USA, Inc. (3) · Aphena Pharma Solutions - Tennessee, LLC (2) · AvPAK (2) · Chartwell RX, LLC (2) · Slate Run Pharmaceuticals, LLC (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.